[1] TREMBLAY Z, MUMBERE D, LAURIN D, et al. Health impacts and characteristics of deprescribing interventions in older adults: protocol for a systematic review and meta-analysis[J]. JMIR Res Protoc, 2021, 10(12): e25200. [2] 王思蒙, 张晨, 孙雪, 等. 社区老年人潜在不适当用药及其应对模式的研究进展 [J]. 中国全科医学, 2022, 25(13): 1551-1556. [3] MASNOON N, SHAKIB S, KALISCH-ELLETT L, et al. What is polypharmacy? A systematic review of definitions [J]. BMC Geriatr, 2017, 17(1): 230. [4] 中国老年保健医学研究会老年内分泌与代谢病分会,中国毒理学会临床毒理专业委员会.老年人多重用药安全管理专家共识 [J]. 中国全科医学, 2018, 21(29): 3533-3544. [5] 王赛, 刘琛, 张兰, 等. 中国老年人潜在不适当用药判断标准(2017年版) [J]. 药物不良反应杂志, 2018, 20(1): 2-8. [6] RAEBEL M A, CHARLES J, DUGAN J, et al. Randomized trial to improve prescribing safety in ambulatory elderly patients [J]. J Am Geriatr Soc, 2007, 55(7): 977-985. [7] TERRELL K M, PERKINS A J, DEXTER P R, et al. Computerized decision support to reduce potentially inappropriate prescribing to older emergency department patients: a randomized, controlled trial [J]. J Am Geriatr Soc, 2009, 57(8): 1388-1394. [8] ERLER A, BEYER M, PETERSEN J J, et al. How to improve drug dosing for patients with renal impairment in primary care - a cluster-randomized controlled trial [J]. BMC Fam Pract, 2012, 13: 91. [9] CLYNE B, SMITH S M, HUGHES C M, et al. Effectiveness of a multifaceted intervention for potentially inappropriate prescribing in older patients in primary care: a cluster-randomized controlled trial (OPTI-SCRIPT Study) [J]. Ann Fam Med, 2015, 13(6): 545-553. [10] BOERSMA M N, HUIBERS C, DRENTH-VAN M A, et al. The effect of providing prescribing recommendations on appropriate prescribing: a cluster-randomized controlled trial in older adults in a preoperative setting [J]. Br J Clin Pharmacol, 2019, 85(9): 1974-1983. [11] COSSETTE B, ÉTHIER J F, JOLY-MISCHLICH T, et al. Reduction in targeted potentially inappropriate medication use in elderly inpatients: a pragmatic randomized controlled trial [J]. Eur J Clin Pharmacol, 2017, 73(10): 1237-1245. [12] PRICE M, DAVIES I, RUSK R, et al. Applying STOPP Guidelines in primary care through electronic medical record decision support: randomized control trial highlighting the importance of data quality [J]. JMIR Med Inform, 2017, 5(2): e15. [13] FRIED T R, NIEHOFF K M, STREET R L, et al. Effect of the tool to reduce inappropriate medications on medication communication and deprescribing [J]. J Am Geriatr Soc, 2017, 65(10): 2265-2271. [14] AVERY A J, RODGERS S, CANTRILL J A, et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis [J]. Lancet, 2012, 379(9823):1310-1319. [15] O'SULLIVAN D, O'MAHONY D, O'CONNOR M N, et al. Prevention of adverse drug reactions in hospitalised older patients using a software-supported structured pharmacist intervention: a cluster randomised controlled trial [J]. Drugs Aging, 2016, 33(1): 63-73. [16] MUTH C, UHLMANN L, HAEFELI W E, et al. Effectiveness of a complex intervention on Prioritising Multimedication in Multimorbidity (PRIMUM) in primary care: results of a pragmatic cluster randomised controlled trial [J]. BMJ Open, 2018, 8(2): e17740. [17] RIECKERT A, REEVES D, DREWELOW E, et al. Use of an electronic decision support tool to reduce polypharmacy in elderly people with chronic diseases: cluster randomised controlled trial [J]. BMJ, 2020, 369: m1822. [18] O'MAHONY D, GUDMUNDSSON A, SOIZA R L, et al. Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial [J]. Age Ageing, 2020, 49(4): 605-614. [19] MCDONALD E G, WU P E, RASHIDI B, et al. The MedSafer Study-electronic decision support for deprescribing in hospitalized older adults: a cluster randomized clinical trial [J]. JAMA Intern Med, 2022, 182(3): 265-273. |